<?xml version="1.0" encoding="UTF-8"?>
<ref id="B35-vaccines-08-00306">
 <label>35.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Black</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Della Cioppa</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Malfroot</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Nacci</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Nicolay</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Pellegrini</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sokal</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Vertruyen</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Safety of mf59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis</article-title>
  <source>Vaccine</source>
  <year>2010</year>
  <volume>28</volume>
  <fpage>7331</fpage>
  <lpage>7336</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2010.08.075</pub-id>
  <pub-id pub-id-type="pmid">20813217</pub-id>
 </element-citation>
</ref>
